[1] |
EVANS C M, PHILLIPS M, MALONE K L, et al. Coordination of di-acetylated histone ligands by the ATAD2 bromodomain[J]. Int J Mol Sci, 2021, 22(17): 9128.
doi: 10.3390/ijms22179128
|
[2] |
BOUSSOUAR F, JAMSHIDIKIA M, MOROZUMI Y, et al. Malignant genome reprogramming by ATAD2[J]. Biochim Biophys Acta-Gene Regul Mech, 2013, 1829(10): 1010-1014.
doi: 10.1016/j.bbagrm.2013.06.003
|
[3] |
ZOU J X, REVENKO A S, LI L B, et al. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ER alpha, is required for coregulator occupancy and chromatin modification[J]. P Natl Acad Sci USA, 2007, 104(46): 18067-18072.
doi: 10.1073/pnas.0705814104
|
[4] |
CIRO M, PROSPERINI E, QUARTO M, et al. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors[J]. Cancer Res, 2009, 69(21): 8491-8498.
doi: 10.1158/0008-5472.CAN-09-2131
pmid: 19843847
|
[5] |
KRAKSTAD C, TANGEN I L, HOIVIK E A, et al. ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma[J]. Oncotarget, 2015, 6(29): 28440-28452.
doi: 10.18632/oncotarget.4955
pmid: 26308378
|
[6] |
ZOU J X, GUO L L, REVENKO A S, et al. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer[J]. Cancer Res, 2009, 69(8): 3339-3346.
doi: 10.1158/0008-5472.CAN-08-3440
pmid: 19318566
|
[7] |
FOURET R, LAFFAIRE J, HOFMAN P, et al. A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma[J]. Clinical Cancer Research, 2012, 18(20): 5606-5616.
doi: 10.1158/1078-0432.CCR-12-0505
pmid: 22914773
|
[8] |
MURAKAMI H, ITO S, TANAKA H, et al. Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis[J]. Anticancer Res, 2013, 33(10): 4299-4307.
pmid: 24122996
|
[9] |
CARON C, LESTRAT C, MARSAL S, et al. Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers[J]. Oncogene, 2010, 29(37): 5171-5181.
doi: 10.1038/onc.2010.259
pmid: 20581866
|
[10] |
SHANG P, MENG F L, LIU Y D, et al. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis[J]. Tumor Biology, 2015, 36(6): 4479-4485.
doi: 10.1007/s13277-015-3089-8
|
[11] |
HONG S, BI M, YAN Z, et al. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells[J]. Neoplasma, 2016, 63(6): 846-855.
pmid: 27565322
|
[12] |
CHEN D, MARUSCHKE M, HAKENBERG O, et al. TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma[J]. Urology, 2017, 102: 265. e1-265.e7.
doi: 10.1016/j.urology.2017.01.011
|
[13] |
SNIDER J, THIBAULT G, HOURY W A. The AAA plus superfamily of functionally diverse proteins[J]. Genome Biol, 2008, 9(4): 216.
doi: 10.1186/gb-2008-9-4-216
|
[14] |
HANSON P I, WHITEHEART S W. AAA+ proteins: Have engine, will work[J]. Nat Rev Mol Cell Biol, 2005, 6(7): 519-529.
doi: 10.1038/nrm1684
|
[15] |
ZENG L, ZHOU M M. Bromodomain: an acetyl-lysine binding domain[J]. FEBS Lett, 2002, 513(1): 124-128.
doi: 10.1016/s0014-5793(01)03309-9
pmid: 11911891
|
[16] |
FILIPPAKOPOULOS P, PICAUD S, MANGOS M, et al. Histone recognition and large-scale structural analysis of the human bromodomain family[J]. Cell, 2012, 149(1): 214-231.
doi: 10.1016/j.cell.2012.02.013
pmid: 22464331
|
[17] |
PONCET-MONTANGE G, ZHAN Y A, BARDENHAGEN J P, et al. Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2[J]. Biochem J, 2015, 466(3): 37-46.
doi: 10.1042/BJ20141296
|
[18] |
MOROZUMI Y, BOUSSOUAR F, TAN M J, et al. Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells[J]. J Mol Cell Biol, 2016, 8(4): 349-362.
doi: 10.1093/jmcb/mjv060
pmid: 26459632
|
[19] |
FILIPPAKOPOULOS P, PICAUD S, MANGOS M, et al. Histone Recognition and large-scale structural analysis of the human bromodomain family[J]. Cell, 2012, 149(1): 214-231.
doi: 10.1016/j.cell.2012.02.013
pmid: 22464331
|
[20] |
OLZSCHA H, FEDOROV O, KESSLER B M, et al. CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation[J]. Cell Chem Biol, 2017, 24(1): 9-23.
doi: S2451-9456(16)30432-9
pmid: 27989401
|
[21] |
HARNER M J, CHAUDER B A, PHAN J, et al. Fragment-based screening of the bromodomain of ATAD2[J]. J Med Chem, 2014, 57(22): 9687-9692.
doi: 10.1021/jm501035j
pmid: 25314628
|
[22] |
GAY J C, ECKENROTH B E, EVANS C M, et al. Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain[J]. Proteins, 2019, 87(2): 157-167.
doi: 10.1002/prot.v87.2
|